Results 241 to 250 of about 1,019,504 (340)
Oct4‐nanoscript, a biomimetic nanoparticle‐based artificial transcription factor, precisely regulates cellular rejuvenation by activating Oct4 target genes, restoring epigenetic marks, and reducing DNA damage. In a progeria model, it effectively rescued aging‐associated pathologies and extended lifespan.
Hongwon Kim+8 more
wiley +1 more source
ADCC: the rock band led by therapeutic antibodies, tumor and immune cells. [PDF]
Vincken R+2 more
europepmc +1 more source
Cobra-venom protein preferentially cytotoxic to certain cell types including Yoshida sarcoma cells and its effects on lipid constituents of cell surface membrane [PDF]
Beatriz M. Braganca, Trupti Patel
openalex +1 more source
This review highlights recent advances in engineering artificial antigen‐presenting cells (aAPCs) as alternatives to dendritic cells for T cell expansion. Key design principles inspired by the immunological synapse are discussed, with emphasis on strategies for polyclonal and antigen‐specific T cell expansion.
Nguyen Thi Nguyen, Yu Seok Youn
wiley +1 more source
Cytotoxic Reactivity of Human Lymphocytes Cultured in Vitro [PDF]
John R. Ortaldo+2 more
openalex +1 more source
Flow‐Induced Vascular Remodeling on‐Chip: Implications for Anti‐VEGF Therapy
Flow‐induced vascular remodeling plays a critical role in network stabilization and function. Using a vasculature‐on‐chip system, this study reveals how physiological VEGF levels and flow affect vascular remodeling and provides insights into tumor vessel normalization.
Fatemeh Mirzapour‐Shafiyi+6 more
wiley +1 more source
CD8<sup>+</sup> T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells. [PDF]
Schiele P+25 more
europepmc +1 more source